To further explore the clinical relevance of CDK6 expression, we performed immunohistochemistry (IHC) analysis of a tissue microarray featuring of 343 cases of breast tumor samples that contains 56 cases of recurrence disease from Kentucky. Here, CDK6 is linked to breast neoplasm.